{"doc_id": "nice_ng109_visual_summary", "source": "NICE", "url": "https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069", "jurisdiction": "UK", "topic": "lower_uti_antimicrobial", "section": "page_1", "text": "UTI (lower): antimicrobial prescribing\nPresentation:\nlower\nurinary tract\ninfection\n(UTI)\nGive advice\nabout managing\nsymptoms with\nself-care\nNon-pregnant women\nConsider a back-up antibiotic\nprescription or immediate antibiotic,\nnoting that the evidence for back-\nup antibiotics was from women not\nneeding immediate treatment\nPregnant women, men, or children\nand young people under 16\n• Send midstream urine for culture\nand susceptibility for pregnant\nwomen and men\n• Send urine for culture and\nsusceptibility or dipstick in line with\nthe NICE guideline on urinary tract\ninfection for under 16s\n• Offer immediate antibiotic\n• Assess and manage fever in under\n5s in line with the NICE guideline on\nfever in under 5s\nIf urine sent for culture and\nsusceptibility, and antibiotic given:\n• review antibiotic choice when\nresults available, and\n• change antibiotic for pregnant\nwomen if bacteria resistant\n• change antibiotic for children\nand young people, men and\nnon-pregnant women if bacteria\nresistant and symptoms\nnot improving\nUse a narrow spectrum antibiotic\nwhen possible\nWith all antibiotic prescriptions,\nadvise:\n• possible adverse effects of\nantibiotics include diarrhoea and\nnausea\n• seeking medical help if symptoms\nworsen at any time, do not improve\nwithin 48 hours of taking the\nantibiotic, or the person becomes\nvery unwell\nWith a back-up antibiotic\nprescription, also advise:\n• antibiotic is not needed\nimmediately\n• use prescription if no improvement\nin 48 hours or symptoms worsen at\nany time\nReassess at any time if symptoms\nworsen rapidly or significantly or do\nnot improve in 48 hours of taking\nantibiotics, sending a urine sample\nfor culture and susceptibility if not\nalready done. Take account of:\n• other possible diagnoses\n• any symptoms or signs suggesting\na more serious illness or condition\n• previous antibiotic use, which may\nhave led to resistance\nRefer to hospital if a person aged 16\nor over has any symptoms or signs\nsuggesting a more serious illness\nor condition (for example, sepsis)\nRefer children and young people to\nhospital in line with the NICE guideline\non urinary tract infection in under 16s\nBackground\n• Lower UTI (cystitis) is a\nbladder infection usually\ncaused by bacteria travelling\nup to the urethra from the\ngastrointestinal tract\nSelf-care\n• Advise paracetamol for pain\nor, if preferred and suitable,\nibuprofen\n• Advise drinking enough fluid to\navoid dehydration\n• No evidence found for\ncranberry products or urine\nalkalinising agents to treat\nlower UTI\nAntibiotics\n• When considering antibiotics,\ntake account of severity\nof symptoms, risk of\ncomplications, previous urine\nculture and susceptibility\nresults, previous antibiotic use\nwhich may have led to resistant\nbacteria and local antimicrobial\nresistance data\nAsymptomatic bacteriuria\n• Asymptomatic bacteriuria is\nsignificant levels of bacteria in\nurine with no UTI symptoms\n• Treated in pregnant women\nbecause risk factor for\npyelonephritis and premature\ndelivery\n• Not screened for or treated in\nnon-pregnant women, men,\nchildren or young people\nThis diagram covers only part of the guideline content. For full details,\nsee NG109 Urinary tract infection (lower): antimicrobial prescribing.\n© NICE 2025. All rights reserved. Subject to Notice of rights.\nLast updated May 2025. ISBN 978-1-4731-6974-6.\n!"}
{"doc_id": "nice_ng109_visual_summary", "source": "NICE", "url": "https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069", "jurisdiction": "UK", "topic": "lower_uti_antimicrobial", "section": "page_2", "text": "UTI (lower): antimicrobial prescribing\nChoice of antibiotic: non-pregnant women aged 16 years and over\nAntibiotic Dosage and course length\nFirst choice\nNitrofurantoin: if estimated\nglomerular filtration rate (eGFR)\n45 ml/minute or more\n100 mg modified-release twice a day (or if unavailable, 50 mg four times a day) for 3 days\nTrimethoprim: if low risk of\nresistance 200 mg twice a day for 3 days\nSecond choice (no improvement in lower UTI symptoms on first choice taken for at least 48 hours, or when first choice not suitable)\nNitrofurantoin: if eGFR\n45 ml/minute or more and not first\nchoice\n100 mg modified-release twice a day (or if unavailable, 50 mg four times a day) for 3 days\nPivmecillinam (a penicillin) 400 mg initial dose, then 200 mg three times a day for a total of 3 days\nFosfomycin 3 g single-dose sachet\nNotes\nFor all antibiotics: See BNF for use and dosing in specific populations, for example, hepatic impairment, renal impairment and breast-feeding. Doses given are by mouth using immediate-release medicines,\nunless otherwise stated. Check any previous urine culture and susceptibility results and antibiotic prescribing and choose antibiotics accordingly.\nNitrofurantoin: See the MHRA advice on monitoring for pulmonary and hepatic adverse reactions to nitrofurantoin. May be used with caution if eGFR 30 to 44 ml/minute to treat uncomplicated lower UTI\ncaused by suspected or proven multidrug resistant bacteria and only if potential benefit outweighs risk (BNF, August 2018).\nTrimethoprim: A lower risk of resistance may be more likely if not used in the past 3 months, previous urine culture suggests susceptibility (but this was not used), and in younger people in areas where local\nepidemiology data suggests resistance is low. A higher risk of resistance may be more likely with recent use and in older people in residential facilities.\n© NICE 2025. All rights reserved. Subject to Notice of rights.\nLast updated May 2025. ISBN 978-1-4731-6974-6.\nIf there are symptoms of pyelonephritis (such as fever) or a complicated UTI, see the NICE guideline on acute pyelonephritis for antibiotic choices"}
{"doc_id": "nice_ng109_visual_summary", "source": "NICE", "url": "https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069", "jurisdiction": "UK", "topic": "lower_uti_antimicrobial", "section": "page_3", "text": "UTI (lower): antimicrobial prescribing\nChoice of antibiotic: children and young people under 16 years\nAntibiotic Dosage and course length\nRefer children under 3 months to paediatric specialist and treat with intravenous antibiotics in line with the NICE guideline on fever in under 5s\nIf there are symptoms of pyelonephritis (such as fever) or a complicated UTI, see the NICE guideline on acute pyelonephritis for antibiotic choices\nChildren aged 3 months and over: first choice\nTrimethoprim: if low risk of\nresistance\n3 to 5 months, 4 mg/kg (maximum 200 mg per dose) or 25 mg twice a day for 3 days\n6 months to 5 years, 4 mg/kg (maximum 200 mg per dose) or 50 mg twice a day for 3 days\n6 to 11 years, 4 mg/kg (maximum 200 mg per dose) or 100 mg twice a day for 3 days\n12 to 15 years, 200 mg twice a day for 3 days\nNitrofurantoin: if eGFR\n45 ml/minute or more\n3 months to 11 years, 750 micrograms/kg four times a day for 3 days\n12 to 15 years, 50 mg four times a day or 100 mg modified-release twice a day for 3 days\nChildren aged 3 months and over: second choice (worsening lower UTI symptoms on first choice taken for at least 48 hours or when first choice not suitable)\nNitrofurantoin: if eGFR\n45 ml/minute or more and not first\nchoice\n3 months to 11 years, 750 micrograms/kg four times a day for 3 days\n12 to 15 years, 50 mg four times a day or 100 mg modified-release twice a day for 3 days\nAmoxicillin (only if culture results\navailable and susceptible)\n3 to 11 months, 125 mg three times a day for 3 days\n1 to 4 years, 250 mg three times a day for 3 days\n5 to 15 years, 500 mg three times a day for 3 days\nCefalexin\n3 to 11 months, 12.5 mg/kg or 125 mg twice a day for 3 days\n1 to 4 years, 12.5 mg/kg twice a day or 125 mg three times a day for 3 days\n5 to 11 years, 12.5 mg/kg twice a day or 250 mg three times a day for 3 days\n12 to 15 years, 500 mg twice a day for 3 days\nNotes\nFor all antibiotics: See BNF for children (BNFC) for use and dosing in specific populations. Age bands apply to children of average size; in practice the prescriber will use these with other factors. Doses given\nare by mouth using immediate release medicines, unless otherwise stated. Check previous urine culture and susceptibility results and antibiotic prescribing. If receiving prophylactic antibiotics, treatment\nshould be with a different antibiotic. If 2 or more antibiotics are appropriate, choose the one with the lowest acquisition cost. Some children may also be able to take a tablet or part-tablet, rather than a liquid\nformulation if the dose is appropriate.\nTrimethoprim: A lower risk of resistance may be more likely if not used in the past 3 months, previous urine culture suggests susceptibility (but this was not used), and in younger people in areas where data\nsuggests resistance is low. Risk of resistance may be higher with recent use and in older people in care homes.\nNitrofurantoin: See the MHRA advice on monitoring for pulmonary and hepatic adverse reactions to nitrofurantoin. May be used with caution if eGFR 30 to 44 ml/minute to treat uncomplicated lower UTI\ncaused by suspected or proven multidrug resistant bacteria and only if potential benefit outweighs risk (BNFC, August 2018).\n© NICE 2025. All rights reserved. Subject to Notice of rights.\nLast updated May 2025. ISBN 978-1-4731-6974-6."}
{"doc_id": "nice_ng109_visual_summary", "source": "NICE", "url": "https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069", "jurisdiction": "UK", "topic": "lower_uti_antimicrobial", "section": "page_4", "text": "UTI (lower): antimicrobial prescribing\nChoice of antibiotic: pregnant women aged 12 years and over\nAntibiotic Dosage and course length\nFirst choice for treating lower UTI\nIf there are symptoms of pyelonephritis (such as fever) or a complicated UTI, see the NICE\nguideline on acute pyelonephritis for antibiotic choices\nIf there are symptoms of pyelonephritis (such as fever) or a complicated UTI, see the NICE\nguideline on acute pyelonephritis for antibiotic choices\nNitrofurantoin (avoid\nat term): if eGFR\n45 ml/minute or more\n100 mg modified-release twice a day (or if unavailable, 50 mg four\ntimes a day) for 7 days\nSecond choice for treating lower UTI (no improvement in lower UTI symptoms on first choice\ntaken for at least 48 hours or when first choice not suitable)\nAmoxicillin (only if\nculture results available\nand susceptible)\n500 mg three times a day for 7 days\nCefalexin 500 mg twice a day for 7 days\nAlternative second choices: consult local microbiologist; choose antibiotics based on culture\nand susceptibility results\nTreating asymptomatic bacteriuria: choose from nitrofurantoin, amoxicillin or cefalexin based on\nrecent culture and susceptibility results\nChoice of antibiotic: men aged 16 years and over\nAntibiotic Dosage and course length\nFirst choice\nTrimethoprim 200 mg twice a day for 7 days\nNitrofurantoin: if eGFR\n45 ml/minute or more\n100 mg modified-release twice a day (or if unavailable, 50 mg four\ntimes a day) for 7 days\nSecond choice (no improvement in UTI symptoms on first choice taken for at least 48 hours or\nwhen first choice not suitable): consider alternative diagnoses and follow recommendations in\nthe NICE antimicrobial prescribing guidelines on acute pyelonephritis or acute prostatitis, basing\nantibiotic choice on recent culture and susceptibility results\nNotes\nFor all antibiotics: See BNF for appropriate use and dosing in specific populations, for example, hepatic impairment and renal impairment. Doses given are by mouth using immediate-release medicines, unless\notherwise stated. Check any previous urine culture and susceptibility results and antibiotic prescribing and choose antibiotics accordingly.\nNitrofurantoin: See the MHRA advice on monitoring for pulmonary and hepatic adverse reactions to nitrofurantoin. Avoid at term in pregnancy; may produce neonatal haemolysis (BNF, June 2018). Not\nrecommended for men with suspected prostate involvement because it is unlikely to reach therapeutic levels in the prostate. May be used with caution if eGFR 30 to 44 ml/minute to treat uncomplicated lower\nUTI caused by suspected or proven multidrug resistant bacteria and only if potential benefit outweighs risk (BNF, August 2018).\n© NICE 2025. All rights reserved. Subject to Notice of rights.\nLast updated May 2025. ISBN 978-1-4731-6974-6."}
